BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology. 1991;48:411-420. [PMID: 1745490 DOI: 10.1159/000226971] [Cited by in Crossref: 351] [Cited by in F6Publishing: 309] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Nakano S, Baba M, Shimada M, Shirao K, Noguchi Y, Kusano C, Natsugoe S, Yoshinaka H, Fukumoto T, Aikou T. How the Lymph Node Metastases Toward Cervico-Upper Mediastinal Region Affect the Outcome of Patients with Carcinoma of the Thoracic Esophagus. Japanese Journal of Clinical Oncology 1999;29:248-51. [DOI: 10.1093/jjco/29.5.248] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
2 Hennessy T. The significance of three-field lymphadenectomy in oesophageal cancer surgery. Surgical Oncology 1994;3:251-3. [DOI: 10.1016/0960-7404(94)90026-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
3 Funami Y, Okuyama K, Shimada Y, Isono K. Anatomic study of the bronchial arteries with special reference to their preservation during the radical dissection of the upper mediastinum lymph nodes. Surgery 1996;119:67-75. [DOI: 10.1016/s0039-6060(96)80216-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Toh Y, Oki E, Minami K, Okamura T. Evaluation of the feasibility and safety of immediate extubation after esophagectomy with extended radical three-field lymph node dissection for thoracic esophageal cancers. Esophagus 2009;6:167-72. [DOI: 10.1007/s10388-009-0198-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Ikeguchi M, Oka S, Gomyo Y, Tsujitani S, Maeta M, Kaibara N. Combined analysis of p53 and retinoblastoma protein expressions in esophageal cancer. Ann Thorac Surg 2000;70:913-7. [PMID: 11016333 DOI: 10.1016/s0003-4975(00)01719-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
6 Law S, Kwong DL, Kwok KF, Wong KH, Chu KM, Sham JS, Wong J. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg. 2003;238:339-347; discussion 347-348. [PMID: 14501500 DOI: 10.1097/01.sla.0000086545.45918.ee] [Cited by in Crossref: 73] [Cited by in F6Publishing: 88] [Article Influence: 3.8] [Reference Citation Analysis]
7 Muroi M, Yoshida M, Kubota N. A Study on the Mode of Recurrence in Cases with Esophagectomy and Extensive Lymph Node Dissections. In: Nabeya K, Hanaoka T, Nogami H, editors. Recent Advances in Diseases of the Esophagus. Tokyo: Springer Japan; 1993. pp. 691-6. [DOI: 10.1007/978-4-431-68246-2_113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
8 Fujita H, Kakegawa T, Yamana H, Shima I, Tanaka H, Ikeda S, Nogami S, Toh Y. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg. 1994;18:266-272. [PMID: 8042333 DOI: 10.1007/bf00294412] [Cited by in Crossref: 58] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
9 Baba M, Natsugoe S, Kusano C, Shirao K, Sane S, Kumanohoso T, Tezuka Y, Sagara M, Yoshinaka H, Fukumoto T, Aikou T. Lymph node metastasis and the recurrence of esophageal carcinoma with emphasis on lymphadenectomy in the neck and superior mediastinum. Surg Today 1995;25:125-30. [DOI: 10.1007/bf00311083] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
10 Ikeguchi M, Ueda T, Fukuda K, Yamaguchi K, Tsujitani S, Kaibara N. Expression of the murine double minute gene 2 oncoprotein in esophageal squamous cell carcinoma as a novel marker for lack of response to chemoradiotreatment. Am J Clin Oncol 2002;25:454-9. [PMID: 12393983 DOI: 10.1097/00000421-200210000-00006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
11 Wang Z, Ren B, Huang J, Yin R, Jiang F, Zhang Q. LncRNA DUXAP10 modulates cell proliferation in esophageal squamous cell carcinoma through epigenetically silencing p21. Cancer Biol Ther 2018;19:998-1005. [PMID: 30215547 DOI: 10.1080/15384047.2018.1470723] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
12 Akiyama S, Kodera Y, Sekiguchi H, Fujiwara M, Sakamoto J, Kondo K, Ito K, Endo T, Takagi H. Preoperative intra-aortic ultrasonography to determine resectability in advanced oesophageal cancer. British Journal of Surgery 1995;82:1671-4. [DOI: 10.1002/bjs.1800821229] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Shimada H, Ochiai T, Okazumi S, Matsubara H, Nabeya Y, Miyazawa Y, Arima M, Funami Y, Hayashi H, Takeda A, Gunji Y, Suzuki T, Kobayashi S. Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery 2000;128:791-8. [DOI: 10.1067/msy.2000.108614] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 3.3] [Reference Citation Analysis]
14 Noguchi T, Wada S, Takeno S, Hashimoto T, Moriyama H, Uchida Y. Two-step three-field lymph node dissection is beneficial for thoracic esophageal carcinoma. Dis Esophagus. 2004;17:27-31. [PMID: 15209737 DOI: 10.1111/j.1442-2050.2004.00353.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
15 Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer. 2002;94:570-575. [PMID: 11900242 DOI: 10.1002/cncr.10190] [Cited by in Crossref: 108] [Cited by in F6Publishing: 100] [Article Influence: 5.4] [Reference Citation Analysis]
16 Gotoda T, Matsumura Y, Kondo H, Ono H, Kanamoto A, Kato H, Watanabe H, Tachimori Y, Nakanishi Y, Kakizoe T. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut. 2000;46:14-19. [PMID: 10601048 DOI: 10.1136/gut.46.1.14] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
17 Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-83. [PMID: 12170022 DOI: 10.1097/00000658-200208000-00005] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
18 Akutsu Y, Matsubara H, Shuto K, Uesato M, Mori M, Hoshino I, Shiratori T, Miyazawa Y, Ito H, Uno T. Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients. World J Surg 2009;33:1002-9. [PMID: 19247705 DOI: 10.1007/s00268-008-9899-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
19 Yano M, Sugimura K, Miyata H, Motoori M, Tanaka K, Omori T, Ohue M, Sakon M. Randomized Comparison of Gastric Tube Reconstruction With and Without Duodenal Diversion Plus Roux-en-Y Anastomosis After Esophagectomy. Ann Surg 2020;272:48-54. [PMID: 31415003 DOI: 10.1097/SLA.0000000000003557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
20 Vrouenraets BC, van Lanschot JJB. Extent of Surgical Resection for Esophageal and Gastroesophageal Junction Adenocarcinomas. Surgical Oncology Clinics of North America 2006;15:781-91. [DOI: 10.1016/j.soc.2006.07.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
21 Park JO, Posner MC. Standard surgical approaches in the management of esophageal cancer. Surgical Oncology Clinics of North America 2002;11:351-63. [DOI: 10.1016/s1055-3207(02)00011-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Kato H, Fukuchi M, Miyazaki T, Nakajima M, Tanaka N, Inose T, Kimura H, Faried A, Saito K, Sohda M, Fukai Y, Masuda N, Manda R, Ojima H, Tsukada K, Kuwano H. Surgical treatment for esophageal cancer. Current issues. Dig Surg 2007;24:88-95. [PMID: 17446703 DOI: 10.1159/000101894] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
23 Kato H. Diagnosis and treatment of esophageal neoplasms. Jpn J Cancer Res 1995;86:993-1009. [PMID: 8567405 DOI: 10.1111/j.1349-7006.1995.tb03012.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
24 Lerut T. Esophageal surgery at the end of the millennium. The Journal of Thoracic and Cardiovascular Surgery 1998;116:1-20. [DOI: 10.1016/s0022-5223(98)70237-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Kakegawa T, Fujita H. A history of esophageal surgery in the twentieth century. Gen Thorac Cardiovasc Surg 2009;57:55-63. [DOI: 10.1007/s11748-008-0381-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
26 Altorki N. Two-field lymph node dissection or three-field lymph node dissection. What's in a name? J Thorac Cardiovasc Surg 2021:S0022-5223(21)01040-0. [PMID: 34321179 DOI: 10.1016/j.jtcvs.2021.06.063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Yano M, Takachi K, Doki Y, Miyashiro I, Kishi K, Noura S, Eguchi H, Yamada T, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Imaoka S. Preoperative chemotherapy for clinically node-positive patients with squamous cell carcinoma of the esophagus. Diseases of the Esophagus 2006;19:158-63. [DOI: 10.1111/j.1442-2050.2006.00558.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
28 Miyata H, Doki Y, Yasuda T, Yamasaki M, Higuchi I, Makari Y, Matsuyama J, Hirao T, Takiguchi S, Fujiwara Y, Monden M. Evaluation of clinical significance of 18F-fluorodeoxyglucose positron emission tomography in superficial squamous cell carcinomas of the thoracic esophagus. Dis Esophagus. 2008;21:144-150. [PMID: 18269650 DOI: 10.1111/j.1442-2050.2007.00743.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
29 Clark G, Roy M, Corcoran B, Carey P. Carcinoma of the oesophagus: The time for a multidiciplinary approach? Surgical Oncology 1996;5:149-64. [DOI: 10.1016/s0960-7404(96)80038-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
30 Nishimaki T, Tanaka O, Suzuki T, Aizawa K, Hatakeyama K, Muto T. Clinical implications of cervical lymph node metastasis patterns in thoracic esophageal cancer. Ann Surg 1994;220:775-81. [PMID: 7986145 DOI: 10.1097/00000658-199412000-00011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
31 Shimada H, Okazumi S, Matsubara H, Nabeya Y, Shiratori T, Shuto K, Shimizu T, Akutsu Y, Tanizawa Y, Hayashi H, Ochiai T. Location and clinical impact of solitary lymph node metastasis in patients with thoracic esophageal carcinoma. The American Journal of Surgery 2006;192:306-10. [DOI: 10.1016/j.amjsurg.2006.01.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
32 Lerut T, Moons J, Coosemans W, Decaluwé H, Decker G, De Leyn P, Nafteux P, Van Raemdonck D. Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center's approach. Surg Oncol Clin N Am 2008;17:485-502, vii-viii. [PMID: 18486879 DOI: 10.1016/j.soc.2008.02.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
33 Schlemper RJ, Kato Y, Stolte M. Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gastroenterol Hepatol. 2000;15 Suppl:G49-G57. [PMID: 11100994 DOI: 10.1046/j.1440-1746.2000.02266.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 3.8] [Reference Citation Analysis]
34 Saito Y, Takeuchi H, Fukuda K, Suda K, Nakamura R, Wada N, Kawakubo H, Kitagawa Y. Size of recurrent laryngeal nerve as a new risk factor for postoperative vocal cord paralysis. Dis Esophagus 2018;31. [PMID: 29701761 DOI: 10.1093/dote/dox162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 Matsubara H. Advances in the surgical treatment of esophageal cancer since 1965. Ann Gastroenterol Surg 2020;4:243-9. [PMID: 32490339 DOI: 10.1002/ags3.12332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Yano M, Motoori M, Tanaka K, Kishi K, Fujiwara Y, Shingai T, Gotoh K, Takahashi H, Noura S, Yamada T, Ohue M, Ohigashi H, Ishikawa O. Preoperative staging of clinically node-negative esophageal cancer by the combination of 18F-fluorodeoxyglucose positron emission tomography and computed tomography (FDG–PET/CT). Esophagus 2012;9:210-6. [DOI: 10.1007/s10388-012-0342-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
37 Yajima S, Oshima Y, Shimada H. Neck dissection for thoracic esophageal squamous cell carcinoma. Int J Surg Oncol 2012;2012:750456. [PMID: 22489266 DOI: 10.1155/2012/750456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
38 Askari A, Munster AB, Jambulingam P, Riaz A. Critical number of lymph node involvement in esophageal and gastric cancer and its impact on long-term survival-A single-center 8-year study. J Surg Oncol 2020;122:1364-72. [PMID: 32803769 DOI: 10.1002/jso.26145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Murakami M, Otsuka K, Goto S, Ariyoshi T, Yamashita T, Aoki T. Thoracoscopic and hand assisted laparoscopic esophagectomy with radical lymph node dissection for esophageal squamous cell carcinoma in the left lateral decubitus position: a single center retrospective analysis of 654 patients. BMC Cancer 2017;17:748. [PMID: 29126387 DOI: 10.1186/s12885-017-3743-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
40 Ueda Y, Shiozaki A, Itoi H, Okamoto K, Fujiwara H, Ichikawa D, Kikuchi S, Fuji N, Itoh T, Ochiai T, Yamagishi H. The Range of Tumor Extension Should Have Precedence over the Location of the Deepest Tumor Center in Determining the Regional Lymph Node Grouping for Widely Extending Esophageal Carcinomas. Japanese Journal of Clinical Oncology 2006;36:775-82. [DOI: 10.1093/jjco/hyl105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
41 Law SY, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg. 1996;83:107-111. [PMID: 8653330 DOI: 10.1002/bjs.1800830134] [Cited by in Crossref: 108] [Cited by in F6Publishing: 93] [Article Influence: 4.2] [Reference Citation Analysis]
42 Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. [Digestive oncology: surgical practices]. J Chir (Paris) 2009;146 Suppl 2:S11-80. [PMID: 19435621 DOI: 10.1016/S0021-7697(09)72398-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
43 Koishi K, Yoshikawa R, Tsujimura T, Hashimoto-Tamaoki T, Kojima S, Yanagi H, Yamamura T, Fujiwara Y. Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer. World J Gastroenterol 2006; 12(47): 7585-7590 [PMID: 17171785 DOI: 10.3748/wjg.v12.i47.7585] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
44 Funai T, Osugi H, Higashino M, Kinoshita H. Estimation of lymph node metastasis by size in patients with intrathoracic oesophageal cancer. Br J Surg 2000;87:1234-9. [PMID: 10971434 DOI: 10.1046/j.1365-2168.2000.01527.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
45 Tabira Y, Yasunaga M, Sakaguchi T, Yamaguchi Y, Okuma T, Kawasuji M. Outcome of histologically node-negative esophageal squamous cell carcinoma. World J Surg 2002;26:1446-51. [PMID: 12297913 DOI: 10.1007/s00268-002-6415-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
46 Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Ectors N. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg. 2004;240:962-72; discussion 972. [PMID: 15570202 DOI: 10.1097/01.sla.0000145925.70409.d7] [Cited by in Crossref: 269] [Cited by in F6Publishing: 236] [Article Influence: 15.8] [Reference Citation Analysis]
47 Noshiro H, Iwasaki H, Kobayashi K, Uchiyama A, Miyasaka Y, Masatsugu T, Koike K, Miyazaki K. Lymphadenectomy along the left recurrent laryngeal nerve by a minimally invasive esophagectomy in the prone position for thoracic esophageal cancer. Surg Endosc. 2010;24:2965-2973. [PMID: 20495981 DOI: 10.1007/s00464-010-1072-4] [Cited by in Crossref: 116] [Cited by in F6Publishing: 101] [Article Influence: 9.7] [Reference Citation Analysis]
48 Kato H, Tachimori Y, Watanabe H, Igaki H, Nakanishi Y, Ochiai A. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection. J Surg Oncol 1996;61:267-72. [PMID: 8627996 DOI: 10.1002/(SICI)1096-9098(199604)61:4<267::AID-JSO6>3.0.CO;2-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
49 Anand S, Kalayarasan R, Chandrasekar S, Gnanasekaran S, Pottakkat B. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters. J Gastrointest Cancer 2019;50:230-5. [PMID: 29344808 DOI: 10.1007/s12029-018-0051-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
50 Shah SV, Chheda YP, Pillai SK, Shah SV. Total oesophagectomy for squamous cell carcinoma with or without standard two field node dissection - a prospective study. Indian J Surg Oncol 2013;4:336-40. [PMID: 24426753 DOI: 10.1007/s13193-013-0264-5] [Reference Citation Analysis]
51 Kanaya S, Matsushita T, Komori J, Sarumaru S, Isobe H, Katayama T, Wada Y, Ohtoshi M. Video-assisted transsternal radical esophagectomy: three-field lymphadenectomy without thoracotomy for esophageal cancer. Surg Laparosc Endosc Percutan Tech 1999;9:353-7. [PMID: 10803398 DOI: 10.1097/00019509-199910000-00007] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
52 Kaisaki S, Kitayama J, Ishigami H, Nagawa H. Solitary Nodal Recurrence in the Dorsal Area of the Thoracic Aorta After a Curative Resection of Esophageal Cancer: Report of Two Cases. Surg Today 2007;37:243-7. [DOI: 10.1007/s00595-006-3349-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
53 Badwe RA, Patil PK, Bhansali MS, Mistry RC, Juvekar RR, Desai PB. Impact of age and sex on survival after curative resection for carcinoma of the esophagus. Cancer 1994;74:2425-9. [PMID: 7922995 DOI: 10.1002/1097-0142(19941101)74:9<2425::aid-cncr2820740906>3.0.co;2-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
54 Law S, Wong J. Two-field dissection is enough for esophageal cancer. Dis Esophagus 2001;14:98-103. [PMID: 11553217 DOI: 10.1046/j.1442-2050.2001.00164.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 2.6] [Reference Citation Analysis]
55 Jamieson GG, Lamb PJ, Thompson SK. The role of lymphadenectomy in esophageal cancer. Ann Surg. 2009;250:206-209. [PMID: 19638911 DOI: 10.1097/sla.0b013e3181b16cd1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
56 Gronnier C, Mariette C. [Lymph node involvement in œsophageal cancer: surgical approach]. Cancer Radiother 2014;18:559-64. [PMID: 25195112 DOI: 10.1016/j.canrad.2014.06.022] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
57 Pramesh CS, Karimundackal G, Jiwnani S, Mehta M. How radical should surgery be for esophageal cancer? Eur J Surg Oncol 2012;38:1144; author reply 1145. [PMID: 22809858 DOI: 10.1016/j.ejso.2012.07.007] [Reference Citation Analysis]
58 Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Ann Surg Oncol 2009;16:2494-501. [PMID: 19526206 DOI: 10.1245/s10434-009-0559-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
59 Calvo FA, Sole CV, Obregón R, Gómez-Espí M, Lozano MA, Gonzalez-Bayon L, García-Sabrido JL. Postchemoradiation resected locally advanced esophageal and gastroesophageal junction carcinoma: long-term outcome with or without intraoperative radiotherapy. Ann Surg Oncol 2013;20:1962-9. [PMID: 23254690 DOI: 10.1245/s10434-012-2810-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
60 Liu Z, Yang T, Xu Z, Cao X. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma. Biomed Pharmacother 2016;82:406-12. [PMID: 27470379 DOI: 10.1016/j.biopha.2016.05.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
61 Xi Y, Ma Z, Shen Y, Wang H, Feng M, Tan L, Wang Q. A novel method for lymphadenectomy along the left laryngeal recurrent nerve during thoracoscopic esophagectomy for esophageal carcinoma. J Thorac Dis 2016;8:24-30. [PMID: 26904208 DOI: 10.3978/j.issn.2072-1439.2016.01.11] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
62 Elias D, Cavalcanti A, Dubé P, Julieron M, Mamelle G, Kac J, Ducreux M, Bonvallot S, Nitenberg G, Lasser P. Circumferential pharyngolaryngectomy with total esophagectomy for locally advanced carcinomas. Ann Surg Oncol 1998;5:511-6. [PMID: 9754759 DOI: 10.1007/BF02303643] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
63 Takagi K, Yamamori H, Morishima Y, Toyoda Y, Nakajima N, Tashiro T. Preoperative immunosuppression: its relationship with high morbidity and mortality in patients receiving thoracic esophagectomy. Nutrition. 2001;17:13-17. [PMID: 11165881 DOI: 10.1016/s0899-9007(00)00504-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
64 Schlemper RJ. International Consensus Classification of Gastrointestinal Epithelial Neoplasia: Usefulness for Esophageal Squamous Epithelium. In: Imamura M, editor. Superficial Esophageal Neoplasm. Tokyo: Springer Japan; 2002. pp. 75-82. [DOI: 10.1007/978-4-431-67873-1_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Gockel I, Sgourakis G, Lyros O, Polotzek U, Schimanski CC, Lang H, Hoppo T, Jobe BA. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev Gastroenterol Hepatol. 2011;5:371-384. [PMID: 21651355 DOI: 10.1586/egh.11.33] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
66 Altorki NK, Girardi L, Skinner DB. En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg. 1997;114:948-955; discussion 955-956. [PMID: 9434690 DOI: 10.1016/s0022-5223(97)70009-6] [Cited by in Crossref: 115] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
67 Kato H, Tachimori Y, Watanabe H, Iizuka T. Evaluation of the new (1987) TNM classification for thoracic esophageal tumors. Int J Cancer. 1993;53:220-223. [PMID: 8425758 DOI: 10.1002/ijc.2910530208] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 1.3] [Reference Citation Analysis]
68 Kinugasa S, Tachibana M, Yoshimura H, Dhar DK, Shibakita M, Ohno S, Kubota H, Masunaga R, Nagasue N. Esophageal resection in elderly esophageal carcinoma patients: improvement in postoperative complications. Ann Thorac Surg. 2001;71:414-418. [PMID: 11235680 DOI: 10.1016/s0003-4975(00)02333-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
69 Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Aoki T, Sugaya M, Miyazawa Y, Hayashi H, Miyazaki S. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol. 2003;83:248-252. [PMID: 12884238 DOI: 10.1002/jso.10275] [Cited by in Crossref: 108] [Cited by in F6Publishing: 110] [Article Influence: 5.7] [Reference Citation Analysis]
70 Sugiura T, Kato H, Tachimori Y, Igaki H, Yamaguchi H, Nakanishi Y. Second primary carcinoma in the gastric tube constructed as an esophageal substitute after esophagectomy. J Am Coll Surg. 2002;194:578-583. [PMID: 12022598 DOI: 10.1016/s1072-7515(02)01135-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
71 Chen X, Han H, Li Y, Zhang Q, Mo K, Chen S. Upregulation of long noncoding RNA HOTTIP promotes metastasis of esophageal squamous cell carcinoma via induction of EMT. Oncotarget 2016;7:84480-5. [PMID: 27806322 DOI: 10.18632/oncotarget.12995] [Cited by in Crossref: 42] [Cited by in F6Publishing: 51] [Article Influence: 10.5] [Reference Citation Analysis]
72 Mukai M, Kubota S, Morita S, Akanuma AA. A pilot study of combination therapy of radiation and local administration of OK-432 for esophageal cancer. Five-year survival and local control rate. Cancer 1995;75:2276-80. [DOI: 10.1002/1097-0142(19950501)75:9<2276::aid-cncr2820750914>3.0.co;2-n] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
73 Ferahköşe Z, Anadol AZ, Gökbayir H, Dursun A, Oztürk E. Three-field lymph node dissection in the treatment of thoracic esophageal carcinoma: the Turkish experience. Dis Esophagus 2006;19:232-7. [PMID: 16866852 DOI: 10.1111/j.1442-2050.2006.00571.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
74 Nozoe T, Kuwano H, Watanabe M, Yasuda M, Sadanaga N, Mimori K, Sugimachi K. The long-term results of pre-operative hyperthermo-chemoradiotherapy for oesophageal carcinoma—a comparison with preoperative radiation therapy alone. European Journal of Surgical Oncology (EJSO) 1995;21:374-8. [DOI: 10.1016/s0748-7983(95)92417-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
75 Gockel I, Kneist W, Keilmann A, Junginger T. Recurrent laryngeal nerve paralysis (RLNP) following esophagectomy for carcinoma. Eur J Surg Oncol 2005;31:277-81. [PMID: 15780563 DOI: 10.1016/j.ejso.2004.10.007] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 5.6] [Reference Citation Analysis]
76 Park S, Hwang Y, Lee HJ, Park IK, Kim YT, Kang CH. Comparison of robot-assisted esophagectomy and thoracoscopic esophagectomy in esophageal squamous cell carcinoma. J Thorac Dis 2016;8:2853-61. [PMID: 27867561 DOI: 10.21037/jtd.2016.10.39] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
77 Baue AE. Important contributions to cardiothoracic surgery by Japanese thoracic and cardiac surgeons. Jpn J Thorac Cardiovasc Surg 2005;53:181-5. [PMID: 15875550 DOI: 10.1007/s11748-005-0101-z] [Reference Citation Analysis]
78 Fang Y, Fang D, Hu J. MicroRNA and its roles in esophageal cancer. Med Sci Monit. 2012;18:RA22-RA30. [PMID: 22367141 DOI: 10.12659/msm.882509] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
79 Tsunoda S, Okumura T, Ito T, Mori Y, Soma T, Watanabe G, Kaganoi J, Itami A, Sakai Y, Shimada Y. Significance of nerve growth factor overexpression and its autocrine loop in oesophageal squamous cell carcinoma. Br J Cancer. 2006;95:322-330. [PMID: 16832412 DOI: 10.1038/sj.bjc.6603255] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
80 Ma GW, Situ DR, Ma QL, Long H, Zhang LJ, Lin P, Rong TH. Three-field vs two-field lymph node dissection for esophageal cancer: A meta-analysis. World J Gastroenterol 2014; 20(47): 18022-18030 [PMID: 25548502 DOI: 10.3748/wjg.v20.i47.18022] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 54] [Article Influence: 6.3] [Reference Citation Analysis]
81 Takiguchi S, Sekimoto M, Fujiwara Y, Yasuda T, Yano M, Monden M. Laparoscopic intragastric surgery for gastric tube cancer following esophagectomy. Surg Endosc 2003;17:1323-4. [PMID: 12799879 DOI: 10.1007/s00464-003-4504-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
82 Shimada Y, Sato F, Maeda M, Watanabe G, Nagatani S, Kaganoi J, Hashimoto Y, Kan T, Li Z, Imamura M. Validity of intraoperative pathological diagnosis of paratracheal lymph node as a strategy for selection of patients for cervical lymph node dissection during esophagectomy. Dis Esophagus 2003;16:246-51. [PMID: 14641319 DOI: 10.1046/j.1442-2050.2003.00338.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
83 Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481-488. [PMID: 12901962 DOI: 10.1016/s1470-2045(03)01167-7] [Cited by in Crossref: 172] [Cited by in F6Publishing: 61] [Article Influence: 9.1] [Reference Citation Analysis]
84 Tachibana M, Kinugasa S, Shibakita M, Tonomoto Y, Hattori S, Hyakudomi R, Yoshimura H, Dhar DK, Nagasue N. Surgical treatment of superficial esophageal cancer. Langenbecks Arch Surg 2006;391:304-21. [PMID: 16830151 DOI: 10.1007/s00423-006-0063-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
85 Shang QX, Yang YS, Xu LY, Li EM, Hu WP, Chen LQ. Prognostic significance and role in TNM stage of tumor deposits in esophageal cancer. J Thorac Dis 2017;9:4461-76. [PMID: 29268516 DOI: 10.21037/jtd.2017.10.60] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
86 Tanaka K, Yano M, Motoori M, Doki Y, Kishi K, Miyashiro I, Shingai T, Gotoh K, Noura S, Takahashi H, Ohue M, Yamada T, Ohigashi H, Ishikawa O. The significance of abdominal para-aortic lymph node metastasis in patients with lower thoracic esophageal cancer: PALN metastasis in esophageal cancer. Diseases of the Esophagus 2012;25:146-52. [DOI: 10.1111/j.1442-2050.2011.01222.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
87 Akutsu Y, Matsubara H. The significance of lymph node status as a prognostic factor for esophageal cancer. Surg Today. 2011;41:1190-1195. [PMID: 21874413 DOI: 10.1007/s00595-011-4542-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
88 Faller J. Surgery for esophageal and cardia cancer in Hungary: a nationwide retrospective five-year survey. Surg Today 1996;26:368-72. [PMID: 8726625 DOI: 10.1007/BF00311610] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
89 Sakai M, Suzuki S, Sano A, Tanaka N, Inose T, Sohda M, Nakajima M, Miyazaki T, Kuwano H. Significance of Lymph Node Capsular Invasion in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2012;19:1911-7. [DOI: 10.1245/s10434-012-2232-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
90 Moon JY, Kim GH, Kim JH, Kim HH, Ryu KD, Park SO, Lee BE, Song GA. Clinicopathologic factors predicting lymph node metastasis in superficial esophageal squamous cell carcinoma. Scand J Gastroenterol. 2014;49:589-594. [PMID: 24641315 DOI: 10.3109/00365521.2013.838604] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
91 Kim SH, Choi YS, Lee SK, Oh H, Choi SH. Comparison of general anesthesia and conscious sedation in procedure-related complications during esophageal endoscopic submucosal dissection. Surg Endosc 2020;34:3560-6. [PMID: 32468261 DOI: 10.1007/s00464-020-07663-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Preston SR, Baker CR, Priest OH, Sudderick RM. Thoracoscopic-assisted four-phase esophagectomy with four-field lymph node dissection for esophageal cancer: case report and description of a new technique. J Laparoendosc Adv Surg Tech A 2012;22:701-4. [PMID: 22845345 DOI: 10.1089/lap.2012.0205] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
93 Giugliano DN, Berger AC, Rosato EL, Palazzo F. Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes. Langenbecks Arch Surg. 2016;401:747-756. [PMID: 27401326 DOI: 10.1007/s00423-016-1469-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
94 Akutsu Y, Matsubara H. Lymph node dissection for esophageal cancer. Gen Thorac Cardiovasc Surg. 2013;61:397-401. [PMID: 23529259 DOI: 10.1007/s11748-013-0237-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
95 Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, Van Raemdonck D. Quality in the surgical treatment of cancer of the esophagus and gastroesophageal junction. European Journal of Surgical Oncology (EJSO) 2005;31:587-94. [DOI: 10.1016/j.ejso.2005.02.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
96 Fan N, Yang H, Zheng J, Chen D, Wang W, Tan Z, Huang Y, Lin P. Comparison of short- and long-term outcomes between 3-field and modern 2-field lymph node dissections for thoracic oesophageal squamous cell carcinoma: a propensity score matching analysis. Interact Cardiovasc Thorac Surg 2019;29:434-41. [PMID: 31135037 DOI: 10.1093/icvts/ivz108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
97 Narumiya K, Nakamura T, Ide H, Takasaki K. Comparison of extended esophagectomy through mini-thoracotomy/laparotomy with conventional thoracotomy/laparotomy for esophageal cancer. Jpn J Thorac Cardiovasc Surg 2005;53:413-9. [DOI: 10.1007/s11748-005-0076-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
98 Stahl M, Vanhoefer U, Stuschke M, Walz M, Müller C, Wilke H. Pre-operative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction. European Journal of Cancer 1998;34:668-73. [DOI: 10.1016/s0959-8049(97)10109-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
99 Leung SF, Griffith JF, Ahuja A, Chan AC. Influence of staging thoracic computed tomography on radiation therapy planning for esophageal carcinoma. J Thorac Imaging. 2002;17:145-150. [PMID: 11956364 DOI: 10.1097/00005382-200204000-00006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
100 Fujita H. History of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery. Surg Today 2015;45:140-9. [PMID: 24519395 DOI: 10.1007/s00595-014-0841-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
101 Yoneyama Y, Ueda Y, Akutsu Y, Matsunaga A, Shimada H, Kato T, Kubota-akizawa M, Okano S, Shibata S, Sueishi K, Hasegawa M, Ochiai T, Yonemitsu Y. Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells. Biochemical and Biophysical Research Communications 2007;355:129-35. [DOI: 10.1016/j.bbrc.2007.01.132] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
102 Schmidt J, Irouschek A, Heinrich S, Oster O, Klein P, Birkholz T. Recurrent laryngeal nerve monitoring during esophagectomy and mediastinal lymph node dissection: a novel approach using a single-lumen endotracheal EMG tube and the EZ-blocker. World J Surg 2012;36:2946-7; author reply 2948. [PMID: 22736347 DOI: 10.1007/s00268-012-1700-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
103 Mukaida H, Hirai T, Yamashita Y, Yoshida K, Hihara J, Kuwahara M, Inoue H, Toge T. Clinical evaluation of adjuvant chemoradiotherapy with CDDP, 5-FU, and VP-16 for advanced esophageal cancer. Jpn J Thorac Cardiovasc Surg 1998;46:11-7. [PMID: 9513519 DOI: 10.1007/BF03217716] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
104 Pramesh C, Kulkarni NN, Mistry RC, Badwe RA. Lymphadenectomy in cancer: time for a paradigm shift? The Lancet Oncology 2006;7:450-1. [DOI: 10.1016/s1470-2045(06)70706-9] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
105 Shuto K, Kono T, Shiratori T, Akutsu Y, Uesato M, Mori M, Narushima K, Imanishi S, Nabeya Y, Yanagawa N, Okazumi S, Koda K, Matsubara H. Diagnostic performance of diffusion-weighted magnetic resonance imaging in assessing lymph node metastasis of esophageal cancer compared with PET. Esophagus 2020;17:239-49. [PMID: 31820208 DOI: 10.1007/s10388-019-00704-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
106 Nakamori M, Iwahashi M, Nakamura M, Yamaue H. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma. J Surg Oncol 2003;84:10-6. [PMID: 12949985 DOI: 10.1002/jso.10286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
107 Akutsu Y, Matsubara H, Shuto K, Shiratori T, Uesato M, Miyazawa Y, Hoshino I, Murakami K, Usui A, Kano M, Miyauchi H. Pre-operative dental brushing can reduce the risk of postoperative pneumonia in esophageal cancer patients. Surgery 2010;147:497-502. [DOI: 10.1016/j.surg.2009.10.048] [Cited by in Crossref: 78] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
108 Zhao J, Xu H, Li W, Chen L, Zhong D, Zhou Y. Intraoperative recurrent laryngeal nerve monitoring during surgery for left lung cancer. J Thorac Cardiovasc Surg 2010;140:578-82. [PMID: 20478574 DOI: 10.1016/j.jtcvs.2010.01.045] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
109 Ni W, Chen J, Xiao Z, Yu S, Zhang W, Zhou Z, Chen D, Feng Q, Chen X, Lin Y, Zhu K, Gao S, Xue Q, Mao Y, Cheng G, Sun K, Liu X, Fang D. Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two-center study. Thorac Cancer 2019;10:1431-40. [PMID: 31102336 DOI: 10.1111/1759-7714.13088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
110 Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide. J Am Coll Surg 2006;202:604-11. [PMID: 16571430 DOI: 10.1016/j.jamcollsurg.2005.12.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
111 Kobayashi M, Irinoda T, Akiyama Y, Meguro E, Hayakawa Y, Funato O, Takagane A. Effect of a selective neutrophil elastase inhibitor on early recovery from body water imbalance after transthoracic esophagectomy. Dis Esophagus. 2010;23:565-571. [PMID: 20353442 DOI: 10.1111/j.1442-2050.2010.01053.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
112 Griffith JF, Chan AC, Ahuja AT, Leung SF, Chow LT, Chung SC, Metreweli C. Neck ultrasound in staging squamous oesophageal carcinoma - a high yield technique. Clin Radiol 2000;55:696-701. [PMID: 10988048 DOI: 10.1053/crad.2000.0502] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
113 Noguchi M, Miyazaki I. Extended lymph node dissection in gastrointestinal cancer. J Surg Oncol 1997;65:57-65. [DOI: 10.1002/(sici)1096-9098(199705)65:1<57::aid-jso12>3.0.co;2-p] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
114 Fujiwara Y, Yoshikawa R, Kamikonya N, Nakayama T, Kitani K, Tsujie M, Yukawa M, Inoue M, Yamamura T. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients. Oncol Rep 2012;28:446-52. [PMID: 22664791 DOI: 10.3892/or.2012.1847] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
115 Fang W, Igaki H, Tachimori Y, Sato H, Daiko H, Kato H. Three-field lymph node dissection for esophageal cancer in elderly patients over 70 years of age. The Annals of Thoracic Surgery 2001;72:867-71. [DOI: 10.1016/s0003-4975(01)02896-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
116 Guo W, Ma Z, Zhao YP, Jiang YG. Controllable metastasis: the trap for the esophageal cancer cells? Med Hypotheses 2010;74:1000-1. [PMID: 20129740 DOI: 10.1016/j.mehy.2010.01.017] [Reference Citation Analysis]
117 Li B, Zhang Y, Miao L, Ma L, Luo X, Zhang Y, Ye T, Li H, Zhang J, Li Y, Zhao K, Fan M, Zhu Z, Wang J, Xu J, Deng Y, Lu Q, Li H, Zhang Y, Pan Y, Liu S, Shao L, Sun Y, Xiang J, Hu H, Chen H. Esophagectomy With Three-Field Versus Two-Field Lymphadenectomy for Middle and Lower Thoracic Esophageal Cancer: Long-Term Outcomes of a Randomized Clinical Trial. J Thorac Oncol 2021;16:310-7. [PMID: 33307192 DOI: 10.1016/j.jtho.2020.10.157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
118 Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Esophageal cancer. Curr Probl Surg 1997;34:765-834. [PMID: 9365422 DOI: 10.1016/s0011-3840(97)80015-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
119 Lerut T, Coosemans W, De Leyn P, Van Raemdonck D, Nafteux P, Moons J. Optimizing Treatment of Carcinoma of the Esophagus and Gastroesophageal Junction. Surgical Oncology Clinics of North America 2001;10:863-84. [DOI: 10.1016/s1055-3207(18)30037-1] [Cited by in Crossref: 17] [Article Influence: 0.8] [Reference Citation Analysis]
120 Teng S, Karl R. Surgical Approaches to Esophageal Cancer: The optimal surgical treatment approach for esophageal cancer remains controversial. Cancer Control 1999;6:36-42. [DOI: 10.1177/107327489900600103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
121 Sato H, Tsubosa Y, Ugumori T. Esophagectomy with three-field lymph node dissection for esophageal carcinoma with a nonrecurrent inferior laryngeal nerve. Jpn J Thorac Cardiovasc Surg 2005;53:502-4. [PMID: 16200893 DOI: 10.1007/s11748-005-0096-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Siewert J, Fink U, Beckurts K, Roder J. Esophageal Cancer: Surgery of squamous cell carcinoma of the esophagus. Annals of Oncology 1994;5:S1-7. [DOI: 10.1093/annonc/5.suppl_3.s1] [Cited by in Crossref: 29] [Article Influence: 1.0] [Reference Citation Analysis]
123 Nakamura T, Ide H, Eguchi R, Ota M, Shimizu S, Isono K. Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire on adenocarcinoma of the esophagus and the esophagogastric junction in Japan. Diseases of the Esophagus 2002;15:219-25. [DOI: 10.1046/j.1442-2050.2002.00262.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
124 Tashiro T, Takagi K, Mashima Y, Yamamori H, Nishizawa M, Nakajima N. Recombinant Human Growth Hormone Improves Postoperative Protein Retention of Patients Receiving Esophagectomy. In: Nabeya K, Hanaoka T, Nogami H, editors. Recent Advances in Diseases of the Esophagus. Tokyo: Springer Japan; 1993. pp. 1017-23. [DOI: 10.1007/978-4-431-68246-2_168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
125 Sun L, Zhang H, Wu K. Esophageal Cancer: Current Options for Therapeutic Management. Gastrointest Tumors 2014;1:105-13. [PMID: 26674591 DOI: 10.1159/000362907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
126 Akiyama S, Sekiguchi H, Fujiwara M, Hibi K, Kasai Y, Kondo K, Ito K, Takagi H. Intra-aortic ultrasonography in advanced esophageal cancer. Semin Surg Oncol 1997;13:234-7. [PMID: 9229409 DOI: 10.1002/(sici)1098-2388(199707/08)13:4<234::aid-ssu3>3.0.co;2-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
127 Chikuba K, Saito T, Uchino S, Sato K, Miyahara M, Tsuda H, Hirohashi S, Kobayashi M. High amplification of the hst-1 gene correlates with haematogenous recurrence after curative resection of oesophageal carcinoma. Br J Surg 1995;82:364-7. [PMID: 7796011 DOI: 10.1002/bjs.1800820327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
128 Park S, Paeng JC, Kang CH, Cheon GJ, Kang KW, Chung J, Lee DS. Dual-time point 18F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes. Eur J Nucl Med Mol Imaging 2018;45:1317-28. [DOI: 10.1007/s00259-018-3981-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
129 Nabeya Y, Ochiai T, Matsubara H, Okazumi S, Shiratori T, Shuto K, Aoki T, Miyazaki S, Gunji Y, Uno T, Ito H, Shimada H. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis. Diseases of the Esophagus 2005;18:388-97. [DOI: 10.1111/j.1442-2050.2005.00521.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
130 Lerut T. Oesophageal carcinoma—past and present studies. European Journal of Surgical Oncology (EJSO) 1996;22:317-23. [DOI: 10.1016/s0748-7983(96)90044-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Miura A, Momma K, Yoshida M. Endoscopic resection for T1a-MM and T1b-SM1 squamous cell carcinoma of the esophagus. Clin J Gastroenterol 2009;2:252-6. [PMID: 26192419 DOI: 10.1007/s12328-009-0098-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
132 Powell AGMT, Hughes DL, Brown J, Larsen M, Witherspoon J, Lewis WG. Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis. Diseases of the Esophagus 2017;30:1-8. [DOI: 10.1093/dote/dow039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
133 Fujita H, Kakegawa T, Yamana H, Shima I, Toh Y, Tomita Y, Fujii T, Yamasaki K, Higaki K, Noake T. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg. 1995;222:654-662. [PMID: 7487213 DOI: 10.1097/00000658-199511000-00008] [Cited by in Crossref: 285] [Cited by in F6Publishing: 236] [Article Influence: 10.6] [Reference Citation Analysis]
134 Tachibana M, Kotoh T, Kinugasa S, Kumar Dhar D, Shibakita M, Ohno S, Masunaga R, Kubota H, Kohno H, Nagasue N. Esophageal Cancer With Cirrhosis of the Liver: Results of Esophagectomy in 18 Consecutive Patients. Ann Surg Oncol 2000;7:758-63. [DOI: 10.1007/s10434-000-0758-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
135 Nakamura T, Hatooka S, Kodaira T, Tachibana H, Tomita N, Nakahara R, Inokuchi H, Mizoguchi N, Takada A, Shinoda M, Fuwa N. Determination of the irradiation field for clinical T1-T3N0M0 thoracic/abdominal esophageal cancer based on the postoperative pathological results. Jpn J Clin Oncol 2009;39:86-91. [PMID: 19042946 DOI: 10.1093/jjco/hyn131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
136 Graboyes EM, Bradley JP, Meyers BF, Nussenbaum B. Efficacy and safety of acute injection laryngoplasty for vocal cord paralysis following thoracic surgery. Laryngoscope 2011;121:2406-10. [PMID: 21994176 DOI: 10.1002/lary.22178] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
137 Makino T, Miyata H, Yamasaki M, Fujiwara Y, Takiguchi S, Nakajima K, Higuchi I, Hatazawa J, Mori M, Doki Y. Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma. Surgery. 2010;148:908-918. [PMID: 20378140 DOI: 10.1016/j.surg.2010.02.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
138 Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, Van Raemdonck D. Cancer of the esophagus and gastro-esophageal junction: potentially curative therapies. Surgical Oncology 2001;10:113-22. [DOI: 10.1016/s0960-7404(01)00027-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
139 Mo R, Chen C, Pan L, Yu A, Wang T. Cervical or thoracic anastomosis for patients with cervicothoracic esophageal squamous cell carcinoma. Ann Transl Med 2018;6:202. [PMID: 30023365 DOI: 10.21037/atm.2018.05.19] [Reference Citation Analysis]
140 Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-83. [PMID: 12170022 DOI: 10.1097/00000658-200208000-00005] [Cited by in Crossref: 295] [Cited by in F6Publishing: 254] [Article Influence: 14.8] [Reference Citation Analysis]
141 Vieth M, Stolte M. Pathology of early upper GI cancers. Best Pract Res Clin Gastroenterol. 2005;19:857-869. [PMID: 16338646 DOI: 10.1016/j.bpg.2005.02.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
142 Lee SJ, Lee KS, Yim YJ, Kim TS, Shim YM, Kim K. Recurrence of squamous cell carcinoma of the oesophagus after curative surgery: rates and patterns on imaging studies correlated with tumour location and pathological stage. Clin Radiol. 2005;60:547-554. [PMID: 15851041 DOI: 10.1016/j.crad.2004.09.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
143 Suda K, Ishida Y, Kawamura Y, Inaba K, Kanaya S, Teramukai S, Satoh S, Uyama I. Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes. World J Surg. 2012;36:1608-1616. [PMID: 22392356 DOI: 10.1007/s00268-012-1538-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 8.2] [Reference Citation Analysis]
144 Altorki NK. The Rationale for Radical Resection. Surgical Oncology Clinics of North America 1999;8:295-305. [DOI: 10.1016/s1055-3207(18)30214-x] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
145 Clark GW, Peters JH, Ireland AP, Ehsan A, Hagen JA, Kiyabu MT, Bremner CG, DeMeester TR. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 1994;58:646-53; discussion 653-4. [PMID: 7944684 DOI: 10.1016/0003-4975(94)90722-6] [Cited by in Crossref: 121] [Cited by in F6Publishing: 100] [Article Influence: 4.3] [Reference Citation Analysis]
146 Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Ishikawa T, Kagami Y. Thoracic esophageal carcinoma above the carina: a more formidable adversary? J Surg Oncol 1997;65:28-33. [PMID: 9179264 DOI: 10.1002/(sici)1096-9098(199705)65:1<28::aid-jso6>3.0.co;2-q] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
147 Fujita H. Ways and tradition of Japan in esophageal surgery for cancer. Gen Thorac Cardiovasc Surg 2020;68:1187-92. [DOI: 10.1007/s11748-020-01369-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
148 Fang WT, Chen WH. Current trends in extended lymph node dissection for esophageal carcinoma. Asian Cardiovasc Thorac Ann. 2009;17:208-213. [PMID: 19592560 DOI: 10.1177/0218492309103332] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
149 Shimada H, Matsubara H, Ochiai T. p53 gene therapy for esophageal cancer. J Gastroenterol. 2002;37 Suppl 14:87-91. [PMID: 12572873 DOI: 10.1007/bf03326422] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
150 Chen FJ, Sun M, Li SQ, Wu QQ, Ji L, Liu ZL, Zhou GZ, Cao G, Jin L, Xie HW. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog. 2013;52:908-915. [PMID: 24151120 DOI: 10.1002/mc.21944] [Cited by in Crossref: 150] [Cited by in F6Publishing: 156] [Article Influence: 15.0] [Reference Citation Analysis]
151 Raja S. Commentary: The optimal lymphadenectomy: The never-ending story. J Thorac Cardiovasc Surg 2021:S0022-5223(21)01134-X. [PMID: 34426007 DOI: 10.1016/j.jtcvs.2021.07.035] [Reference Citation Analysis]
152 Kooguchi K, Kobayashi A, Kitamura Y, Ueno H, Urata Y, Onodera H, Hashimoto S. Elevated expression of inducible nitric oxide synthase and inflammatory cytokines in the alveolar macrophages after esophagectomy: . Critical Care Medicine 2002;30:71-6. [DOI: 10.1097/00003246-200201000-00011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
153 Udagawa H, Ueno M, Shinohara H, Haruta S, Lee S, Momose K, Tsurumaru M. Should lymph nodes along the thoracic duct be dissected routinely in radical esophagectomy? Esophagus 2014;11:204-10. [DOI: 10.1007/s10388-014-0433-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
154 Colvin H, Mizushima T, Eguchi H, Takiguchi S, Doki Y, Mori M. Gastroenterological surgery in Japan: The past, the present and the future. Ann Gastroenterol Surg 2017;1:5-10. [PMID: 29863129 DOI: 10.1002/ags3.12008] [Cited by in Crossref: 110] [Cited by in F6Publishing: 83] [Article Influence: 22.0] [Reference Citation Analysis]
155 Ota M, Ide H, Hayashi K, Murata Y, Eguchi R, Nakamura T, Narumiya K, Oi I, Takasaki K. Multimodality treatments with endoscopic mucosal resection of esophageal squamous cell carcinoma with submucosal invasion. Surg Endosc. 2003;17:1429-1433. [PMID: 12802668 DOI: 10.1007/s00464-002-8708-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
156 Jang HJ, Lee HS, Kim MS, Lee JM, Zo JI. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma. Ann Thorac Surg 2011;92:1091-7. [PMID: 21704967 DOI: 10.1016/j.athoracsur.2011.03.093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
157 Kaburagi T, Takeuchi H, Fujii H, Saikawa Y, Murakami K, Fukada J, Shigematsu N, Ozawa S, Ando N, Kitagawa Y. Initial experience of individualized chemoradiotherapy for superficial esophageal cancers based on the sentinel lymph node concept. Esophagus 2012;9:147-52. [DOI: 10.1007/s10388-012-0317-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
158 Miyasaka D, Okushiba S, Sasaki T, Ebihara Y, Kawada M, Kawarada Y, Kitashiro S, Katoh H, Miyamoto M, Shichinohe T, Hirano S. Clinical evaluation of the feasibility of minimally invasive surgery in esophageal cancer. Asian J Endosc Surg 2013;6:26-32. [PMID: 23116427 DOI: 10.1111/j.1758-5910.2012.00158.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
159 Lee RB, Miller JI. Esophagectomy for cancer. Surg Clin North Am. 1997;77:1169-1196. [PMID: 9347836 DOI: 10.1016/s0039-6109(05)70610-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
160 Suzuki H, Saito Y, Ikehara H, Oda I. Evaluation of visualization of squamous cell carcinoma of esophagus and pharynx using an autofluorescence imaging videoendoscope system. J Gastroenterol Hepatol. 2009;24:1834-1839. [PMID: 19780882 DOI: 10.1111/j.1440-1746.2009.05941.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
161 Nakamura M, Iwahashi M, Nakamori M, Ishida K, Naka T, Iida T, Katsuda M, Tsuji T, Nakatani Y, Yamaue H. An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbecks Arch Surg 2008;393:127-33. [PMID: 18071746 DOI: 10.1007/s00423-007-0253-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
162 Akutsu Y, Matsubara H, Kano M, Usui A, Yoneyama Y, Ikeda N, Komatsu A, Yusup G. Correlation between gp96 expression and the surgical outcome in patients with esophageal squamous cell carcinoma. Ann Surg Oncol 2011;18:832-7. [PMID: 20839070 DOI: 10.1245/s10434-010-1128-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
163 Shinkai M, Niwa Y, Arisawa T, Ohmiya N, Goto H, Hayakawa T. Evaluation of prognosis of squamous cell carcinoma of the oesophagus by endoscopic ultrasonography. Gut. 2000;47:120-125. [PMID: 10861273 DOI: 10.1136/gut.47.1.120] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.4] [Reference Citation Analysis]
164 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145:12S21-9. [PMID: 22794068 DOI: 10.1016/S0021-7697(08)45005-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
165 Matsuda S, Takeuchi H, Kawakubo H, Kitagawa Y. Three-field lymph node dissection in esophageal cancer surgery. J Thorac Dis 2017;9:S731-40. [PMID: 28815069 DOI: 10.21037/jtd.2017.03.171] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
166 Gockel I, Kneist W, Junginger T. Influence of splenectomy on perioperative morbidity and long-term survival after esophagectomy in patients with esophageal carcinoma. Diseases of the Esophagus 2005;18:311-5. [DOI: 10.1111/j.1442-2050.2005.00512.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
167 Katsuta T, Saito T, Shigemitsu Y, Kinoshita T, Shiraishi N, Kitano S. Relation between tumour necrosis factor alpha and interleukin 1beta producing capacity of peripheral monocytes and pulmonary complications following oesophagectomy. Br J Surg. 1998;85:548-553. [PMID: 9607545 DOI: 10.1046/j.1365-2168.1998.00656.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
168 Tanigawa N, Matsumura M, Amaya H, Kitaoka A, Shimomatsuya T, Lu C, Muraoka R, Tanaka T. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 1997;79:220-5. [DOI: 10.1002/(sici)1097-0142(19970115)79:2<220::aid-cncr4>3.0.co;2-o] [Cited by in Crossref: 69] [Article Influence: 2.8] [Reference Citation Analysis]
169 Aiko S, Yoshizumi Y, Matsuyama T, Sugiura Y, Maehara T. Influences of thoracic duct blockage on early enteral nutrition for patients who underwent esophageal cancer surgery. Jpn J Thorac Caridovasc Surg 2003;51:263-71. [DOI: 10.1007/bf02719376] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
170 Watanabe M, Kuwano H, Araki K, Kawaguchi H, Saeki H, Kitamura K, Ohno S, Sugimachi K. Prognostic factors in patients with submucosal carcinoma of the oesophagus. Br J Cancer 2000;83:609-13. [PMID: 10944600 DOI: 10.1054/bjoc.2000.1288] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
171 Yajima K, Kosugi S, Kanda T, Matsuki A, Hatakeyama K. Risk factors of reflux esophagitis in the cervical remnant following esophagectomy with gastric tube reconstruction. World J Surg 2009;33:284-9. [PMID: 19083053 DOI: 10.1007/s00268-008-9856-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
172 Tabira Y, Yasunaga M, Tanaka M, Nakano K, Sakaguchi T, Nagamoto N, Ogi S, Kitamura N. Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma. J Am Coll Surg. 2000;191:232-237. [PMID: 10989896 DOI: 10.1016/s1072-7515(00)00348-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
173 Xie JJ, Xu LY, Xie YM, Zhang HH, Cai WJ, Zhou F, Shen ZY, Li EM. Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Int J Cancer 2009;124:2549-58. [PMID: 19165868 DOI: 10.1002/ijc.24216] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 4.0] [Reference Citation Analysis]
174 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145S4:12S21-9. [PMID: 22793981 DOI: 10.1016/S0021-7697(08)74718-5] [Reference Citation Analysis]
175 Nishihira T, Sayama J, Ueda H, Sugawara K, Takano R, Sagawa J, Katayama M, Shineha R, Hirayama K, Mori S. Lymph flow and lymph node metastasis in esophageal cancer. Surg Today 1995;25:307-17. [PMID: 7633121 DOI: 10.1007/BF00311252] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
176 Saito T, Shimoda K, Shigemitsu Y, Kinoshita T, Miyahara M, Kobayashi M. Extensive lymphadenectomy for thoracic esophageal carcinoma: a two-stage operation for high-risk patients. Surg Today 1994;24:610-5. [PMID: 7949769 DOI: 10.1007/BF01833725] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
177 Shimada H, Okazumi S, Matsubara H, Shiratori T, Akutsu Y, Nabeya Y, Tanizawa T, Matsushita K, Hayashi H, Isono K, Ochiai T. Long-term Results after Dissection of Positive Thoracic Lymph Nodes in Patients with Esophageal Squamous Cell Carcinoma. World J Surg 2008;32:255-61. [DOI: 10.1007/s00268-007-9213-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
178 Matsuda S, Takeuchi H, Kawakubo H, Shimada A, Fukuda K, Nakamura R, Takahashi T, Wada N, Kameyama K, Kitagawa Y. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct. Medicine (Baltimore) 2016;95:e3839. [PMID: 27310961 DOI: 10.1097/MD.0000000000003839] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 6.4] [Reference Citation Analysis]
179 Xu Y, Wang J, Qiu M, Xu L, Li M, Jiang F, Yin R, Xu L. Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma. Tumour Biol 2015;36:1643-51. [PMID: 25366138 DOI: 10.1007/s13277-014-2763-6] [Cited by in Crossref: 109] [Cited by in F6Publishing: 111] [Article Influence: 13.6] [Reference Citation Analysis]
180 Yano M, Yasuda T, Miyata H, Fujiwara Y, Takiguchi S, Monden M. Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus. J Surg Oncol 2005;89:244-50. [DOI: 10.1002/jso.20209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
181 Ogawa R, Ishiguro H, Kimura M, Funahashi H, Wakasugi T, Ando T, Shiozaki M, Takeyama H. NOTCH1 expression predicts patient prognosis in esophageal squamous cell cancer. Eur Surg Res 2013;51:101-7. [PMID: 24217574 DOI: 10.1159/000355674] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
182 Shim YM, Kim HK, Kim K. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma. J Thorac Oncol 2010;5:707-12. [PMID: 20421764 DOI: 10.1097/JTO.0b013e3181d3ccb2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
183 Shimada H, Matsubara H, Okazumi S, Isono K, Ochiai T. Improved Surgical Results in Thoracic Esophageal Squamous Cell Carcinoma: A 40-year Analysis of 792 Patients. J Gastrointest Surg 2008;12:518-26. [DOI: 10.1007/s11605-007-0280-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
184 Yano M, Takachi K, Doki Y, Miyashiro I, Kishi K, Noura S, Eguchi H, Yamada T, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Matsunaga T, Imaoka S. Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer. Dis Esophagus 2006;19:73-7. [PMID: 16643173 DOI: 10.1111/j.1442-2050.2006.00543.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
185 Tougeron D, Richer JP, Silvain C. Management of esophageal adenocarcinoma. J Visc Surg. 2011;148:e161-e170. [PMID: 21715236 DOI: 10.1016/j.jviscsurg.2011.05.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
186 Bonvalot S, Bouvard N, Lothaire P, Maurel J, Galateau F, Ségol P, Gignoux M. Contribution of cervical ultrasound and ultrasound fineneedle aspiration biopsy to the staging of thoracic oesophageal carcinoma. European Journal of Cancer 1996;32:893-5. [DOI: 10.1016/0959-8049(96)00034-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
187 Dresner SM, Wayman J, Shenfine J, Harris A, Hayes N, Griffin SM. Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Br J Surg. 2000;87:362-373. [PMID: 10718968 DOI: 10.1046/j.1365-2168.2000.01541.x] [Cited by in Crossref: 154] [Cited by in F6Publishing: 138] [Article Influence: 7.7] [Reference Citation Analysis]
188 Gockel I, Exner C, Junginger T. Morbidity and mortality after esophagectomy for esophageal carcinoma: a risk analysis. World J Surg Oncol 2005;3:37. [PMID: 15969746 DOI: 10.1186/1477-7819-3-37] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
189 Cense HA, van Eijck CH, Tilanus HW. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract Res Clin Gastroenterol. 2006;20:893-906. [PMID: 16997168 DOI: 10.1016/j.bpg.2006.03.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
190 Schuchert MJ, Luketich JD, Landreneau RJ. Management of esophageal cancer. Curr Probl Surg 2010;47:845-946. [PMID: 20937424 DOI: 10.1067/j.cpsurg.2010.07.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
191 Xiao ZF, Yang ZY, Miao YJ, Wang LH, Yin WB, Gu XZ, Zhang DC, Sun KL, Chen GY, He J. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys. 2005;62:82-90. [PMID: 15850906 DOI: 10.1016/j.ijrobp.2004.08.046] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 4.5] [Reference Citation Analysis]
192 Sharma S, Fujita H, Yamana H, Kakegawa T. Patterns of lymph node metastasis in 3-field dissection for carcinoma in the thoracic esophagus. Surg Today 1994;24:410-4. [PMID: 8054811 DOI: 10.1007/BF01427033] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
193 Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Tabara H, Nagasue N. En-bloc esophagectomy for esophageal cancer. The American Journal of Surgery 2004;188:254-60. [DOI: 10.1016/j.amjsurg.2004.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
194 Shioyama Y, Nakamura K, Sasaki T, Ooga S, Urashima Y, Kimura M, Uehara S, Terashima H, Honda H. Clinical results of radiation therapy for stage I esophageal cancer: a single institutional experience. Am J Clin Oncol. 2005;28:75-80. [PMID: 15685039 DOI: 10.1097/01.coc.0000139021.91718.ee] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
195 Li H, Zhang ZR. Current status and future direction of lymph node dissection in radical surgery for esophageal cancer. J Thorac Dis 2019;11:S1678-82. [PMID: 31516741 DOI: 10.21037/jtd.2019.05.51] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
196 Akutsu Y, Yasuda S, Nagata M, Izumi Y, Okazumi S, Shimada H, Nakatani Y, Tsujii H, Kamada T, Yamada S, Matsubara H. A phase I/II clinical trial of preoperative short-course carbon-ion radiotherapy for patients with squamous cell carcinoma of the esophagus: Carbon-Ion Therapy for Esophageal Cancer. J Surg Oncol 2012;105:750-5. [DOI: 10.1002/jso.22127] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
197 Matsuda S, Kawakubo H, Takeuchi H, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Kitagawa Y. Prognostic impact of thoracic duct lymph node metastasis in esophageal squamous cell carcinoma. Ann Gastroenterol Surg 2021;5:321-30. [PMID: 34095722 DOI: 10.1002/ags3.12432] [Reference Citation Analysis]
198 Hirano M, Tanaka S, Fujita M, Fujita H. Vocal cord paralysis caused by esophageal cancer surgery. Ann Otol Rhinol Laryngol 1993;102:182-5. [PMID: 8457119 DOI: 10.1177/000348949310200304] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
199 Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005;189:98-109. [PMID: 15701501 DOI: 10.1016/j.amjsurg.2004.10.001] [Cited by in Crossref: 118] [Cited by in F6Publishing: 120] [Article Influence: 6.9] [Reference Citation Analysis]
200 Takeuchi H, Kawakubo H, Kitagawa Y. Current status of minimally invasive esophagectomy for patients with esophageal cancer. Gen Thorac Cardiovasc Surg. 2013;61:513-521. [PMID: 23661109 DOI: 10.1007/s11748-013-0258-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
201 Ji X, Cai J, Chen Y, Chen LQ. Lymphatic spreading and lymphadenectomy for esophageal carcinoma. World J Gastrointest Surg 2016; 8(1): 90-94 [PMID: 26843917 DOI: 10.4240/wjgs.v8.i1.90] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
202 Li H, Yang S, Zhang Y, Xiang J, Chen H. Thoracic recurrent laryngeal lymph node metastases predict cervical node metastases and benefit from three-field dissection in selected patients with thoracic esophageal squamous cell carcinoma. J Surg Oncol. 2012;105:548-552. [PMID: 22105736 DOI: 10.1002/jso.22148] [Cited by in Crossref: 19] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
203 Schröder W, Mönig SP, Baldus SE, Gutschow C, Schneider PM, Hölscher AH. Frequency of nodal metastases to the upper mediastinum in Barrett's cancer. Ann Surg Oncol 2002;9:807-11. [PMID: 12374665 DOI: 10.1007/BF02574504] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
204 Yamagata Y, Saito K, Hirano K, Oya M. Long-term outcomes and safety of radical transmediastinal esophagectomy with preoperative docetaxel, cisplatin, and 5-fluorouracil combination chemotherapy for locally advanced squamous cell carcinoma of the thoracic esophagus. World J Surg Oncol 2020;18:252. [PMID: 32962718 DOI: 10.1186/s12957-020-02023-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
205 Watson A. Diagnosis and therapy for advanced esophageal cancer: . Current Opinion in Gastroenterology 2003;19:400-5. [DOI: 10.1097/00001574-200307000-00013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
206 Ikebe M, Morita M, Yamamoto M, Toh Y. Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management. Gen Thorac Cardiovasc Surg 2016;64:386-94. [DOI: 10.1007/s11748-016-0655-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
207 Zhu Y, Li M, Kong L, Yu J. Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation. Onco Targets Ther 2016;9:4187-96. [PMID: 27471393 DOI: 10.2147/OTT.S104221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
208 Akagi I, Miyashita M, Takahashi K, Matsutani T, Matsuda A, Nomura T, Makino H, Hagiwara N, Uchida E. Determination of urinary trypsin inhibitor provides insight into postoperative complications in patients following esophagectomy. Exp Ther Med. 2012;4:84-88. [PMID: 23060927 DOI: 10.3892/etm.2012.554] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
209 Boone J, Hobbelink MG, Schipper ME, Vleggaar FP, Borel Rinkes IH, de Haas RJ, Ruurda JP, van Hillegersberg R. Sentinel node biopsy during thoracolaparoscopic esophagectomy for advanced esophageal cancer. World J Surg Oncol 2016;14:117. [PMID: 27094390 DOI: 10.1186/s12957-016-0866-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
210 Boone J, Livestro DP, Elias SG, Borel Rinkes IH, van Hillegersberg R. International survey on esophageal cancer: part I surgical techniques. Dis Esophagus. 2009;22:195-202. [PMID: 19191856 DOI: 10.1111/j.1442-2050.2008.00929.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
211 Fujiwara Y, Yoshikawa R, Kamikonya N, Nakayama T, Kitani K, Tsujie M, Yukawa M, Hara J, Yamamura T, Inoue M. Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma. Mol Clin Oncol 2013;1:773-9. [PMID: 24649245 DOI: 10.3892/mco.2013.128] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
212 Shimada H, Okazumi S, Shiratori T, Akutsu Y, Matsubara H. Mode of lymphadenectomy and surgical outcome of upper thoracic esophageal squamous cell carcinoma. J Gastrointest Surg. 2009;13:619-625. [PMID: 19156473 DOI: 10.1007/s11605-008-0790-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
213 Udagawa H. Past, present, and future of three-field lymphadenectomy for thoracic esophageal cancer. Ann Gastroenterol Surg 2020;4:324-30. [PMID: 32724875 DOI: 10.1002/ags3.12338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
214 Kurihara N, Imai K, Minamiya Y, Saito H, Takashima S, Kudo S, Kawaharada Y, Ogawa J. Hoarseness caused by arytenoid dislocation after surgery for lung cancer. Gen Thorac Cardiovasc Surg 2014;62:730-3. [DOI: 10.1007/s11748-013-0282-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
215 Sugimachi K. Advances in the surgical treatment of oesophageal cancer. British Journal of Surgery 1998;85:289-90. [DOI: 10.1046/j.1365-2168.1998.00705.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
216 Tang WW, Liu ZH, Yang TX, Wang HJ, Cao XF. Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma. Onco Targets Ther 2016;9:4289-93. [PMID: 27478386 DOI: 10.2147/OTT.S99195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
217 Saito H, Sato T, Miyazaki M. Extramural lymphatic drainage from the thoracic esophagus based on minute cadaveric dissections: fundamentals for the sentinel node navigation surgery for the thoracic esophageal cancers. Surg Radiol Anat 2007;29:531-42. [PMID: 17710360 DOI: 10.1007/s00276-007-0257-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
218 Collard JM, Otte JB, Fiasse R, Laterre PF, De Kock M, Longueville J, Glineur D, Romagnoli R, Reynaert M, Kestens PJ. Skeletonizing en bloc esophagectomy for cancer. Ann Surg 2001;234:25-32. [PMID: 11420480 DOI: 10.1097/00000658-200107000-00005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
219 Ma H, Li Y, Ding Z, Liu X, Xu J, Qin J. The clinical significance of subcarinal lymph node dissection in the radical resection of oesophageal cancer. Interact Cardiovasc Thorac Surg 2013;16:839-43. [PMID: 23475120 DOI: 10.1093/icvts/ivt070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
220 Tsunoda S, Okumura T, Ito T, Kondo K, Ortiz C, Tanaka E, Watanabe G, Itami A, Sakai Y, Shimada Y. ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Oncology. 2006;71:251-258. [PMID: 17671398 DOI: 10.1159/000106787] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
221 Law SY, Wong J. Esophageal cancer surgery: The value of controlled clinical trials. Semin Surg Oncol 1997;13:281-7. [DOI: 10.1002/(sici)1098-2388(199707/08)13:4<281::aid-ssu10>3.0.co;2-v] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
222 Baba M, Natsugoe S, Shimada M, Nakano S, Noguchi Y, Kawachi K, Kusano C, Aikou T. Does hoarseness of voice from recurrent nerve paralysis after esophagectomy for carcinoma influence patient quality of life? J Am Coll Surg 1999;188:231-6. [PMID: 10065810 DOI: 10.1016/s1072-7515(98)00295-6] [Cited by in Crossref: 70] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
223 Takagi K, Yamamori H, Furukawa K, Miyazaki M, Tashiro T. Perioperative supplementation of EPA reduces immunosuppression induced by postoperative chemoradiation therapy in patients with esophageal cancer. Nutrition 2001;17:478-9. [DOI: 10.1016/s0899-9007(01)00557-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
224 Li B, Hu H, Zhang Y, Zhang J, Miao L, Ma L, Luo X, Zhang Y, Ye T, Li H, Li Y, Shen L, Zhao K, Fan M, Zhu Z, Wang J, Xu J, Deng Y, Lu Q, Li H, Zhang Y, Pan Y, Liu S, Hu H, Shao L, Sun Y, Xiang J, Chen H. Three-field versus two-field lymphadenectomy in transthoracic oesophagectomy for oesophageal squamous cell carcinoma: short-term outcomes of a randomized clinical trial. Br J Surg 2020;107:647-54. [PMID: 32108326 DOI: 10.1002/bjs.11497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
225 Law S, Wong J. Lymph node dissection in surgical treatment of esophageal neoplasms. Surg Oncol Clin N Am 2007;16:115-31. [PMID: 17336240 DOI: 10.1016/j.soc.2006.10.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
226 Tabira Y, Okuma T, Kondo K, Kitamura N. Indications for three-field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus. The Journal of Thoracic and Cardiovascular Surgery 1999;117:239-45. [DOI: 10.1016/s0022-5223(99)70418-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
227 Tsai TC, Miller J, Andolfi C, Whang B, Fisichella PM. Surgical evaluation of lymph nodes in esophageal adenocarcinoma: Standardized approach or personalized medicine? Eur J Surg Oncol 2018;44:1177-80. [PMID: 29751947 DOI: 10.1016/j.ejso.2018.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
228 Cho JW, Choi SC, Jang JY, Shin SK, Choi KD, Lee JH, Kim SG, Sung JK, Jeon SW, Choi IJ, Kim GH, Jee SR, Lee WS, Jung HY; Korean ESD Study Group. Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View. Clin Endosc. 2014;47:523-529. [PMID: 25505718 DOI: 10.5946/ce.2014.47.6.523] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
229 Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Katada T, Harata K, Tanaka T, Fujii Y. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol. 2009;42:102-109. [PMID: 19536617 DOI: 10.1007/s00795-009-0443-1] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 5.8] [Reference Citation Analysis]
230 Junginger T, Gockel I, Heckhoff S. A comparison of transhiatal and transthoracic resections on the prognosis in patients with squamous cell carcinoma of the esophagus. European Journal of Surgical Oncology (EJSO) 2006;32:749-55. [DOI: 10.1016/j.ejso.2006.03.048] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
231 Takagi K, Yamamori H, Toyoda Y, Nakajima N, Tashiro T. Modulating effects of the feeding route on stress response and endotoxin translocation in severely stressed patients receiving thoracic esophagectomy. Nutrition. 2000;16:355-360. [PMID: 10793304 DOI: 10.1016/s0899-9007(00)00231-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
232 Baba M, Aikou T, Yoshinaka H, Natsugoe S, Fukumoto T, Shimazu H, Akazawa K. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994;219:310-6. [PMID: 8147613 DOI: 10.1097/00000658-199403000-00012] [Cited by in Crossref: 184] [Cited by in F6Publishing: 153] [Article Influence: 6.6] [Reference Citation Analysis]
233 Blom D, Peters JH. Surgery, radiotherapy, and chemotherapy in carcinoma of the esophagus. Curr Opin Gastroenterol 2000;16:392-9. [PMID: 17031107 DOI: 10.1097/00001574-200007000-00017] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
234 Fujita H. President's address of the 65th annual scientific meeting of the Japanese Association for Thoracic Surgery: challenges for advanced esophageal cancer. Gen Thorac Cardiovasc Surg 2013;61:201-7. [PMID: 23404311 DOI: 10.1007/s11748-013-0213-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
235 Huang W, Li B, Gong H, Yu J, Sun H, Zhou T, Zhang Z, Liu X. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases. Radiother Oncol. 2010;95:229-233. [PMID: 20189259 DOI: 10.1016/j.radonc.2010.01.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
236 Blom D. Surgical management of esophageal malignancy. Curr Gastroenterol Rep 2003;5:192-7. [DOI: 10.1007/s11894-003-0019-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
237 Yano M, Motoori M, Tanaka K, Kishi K, Miyashiro I, Shingai T, Gotoh K, Noura S, Takahashi H, Yamada T, Ohue M, Ohigashi H, Ishikawa O. Prevention of gastroduodenal content reflux and delayed gastric emptying after esophagectomy: gastric tube reconstruction with duodenal diversion plus Roux-en-Y anastomosis. Dis Esophagus 2012;25:181-7. [PMID: 21819481 DOI: 10.1111/j.1442-2050.2011.01229.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
238 Grotenhuis BA, Wijnhoven BP, Grüne F, van Bommel J, Tilanus HW, van Lanschot JJ. Preoperative risk assessment and prevention of complications in patients with esophageal cancer. J Surg Oncol 2010;101:270-8. [PMID: 20082349 DOI: 10.1002/jso.21471] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
239 Kobayashi M, Kawachi H, Takizawa T, Uchida K, Sekine M, Kumagai J, Momma K, Nemoto T, Akashi T, Funata N, Eishi Y, Koike M. p53 Mutation analysis of low-grade dysplasia and high-grade dysplasia/carcinoma in situ of the esophagus using laser capture microdissection. Oncology 2006;71:237-45. [PMID: 17652955 DOI: 10.1159/000106448] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
240 Blom D, Peters JH, Demeester TR. Controversies in the current therapy of carcinoma of the esophagus1 1No competing interests declared. Journal of the American College of Surgeons 2002;195:241-50. [DOI: 10.1016/s1072-7515(02)01221-8] [Cited by in Crossref: 12] [Article Influence: 0.6] [Reference Citation Analysis]
241 Del Genio A, Rossetti G, Napolitano V, Maffettone V, Renzi A, Brusciano L, Russo G, Del Genio G. Laparoscopic esophagectomy in the palliative treatment of advanced esophageal cancer after radiochemotherapy. Surg Endosc 2004;18:1789-94. [DOI: 10.1007/s00464-003-9243-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
242 Ma J, Fan Y, Feng T, Chen F, Xu Z, Li S, Lin Q, He X, Shi W, Liu Y, Liu Z, Zhu B, Cao X. HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression. Oncotarget. 2017;8:86410-86422. [PMID: 29156804 DOI: 10.18632/oncotarget.21195] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
243 Bona D, Lombardo F, Matsushima K, Cavalli M, Lastraioli C, Bonitta G, Cirri S, Danelli P, Aiolfi A. Three-field versus two-field lymphadenectomy for esophageal squamous cell carcinoma: A long-term survival meta-analysis. Surgery 2021:S0039-6060(21)00844-8. [PMID: 34544603 DOI: 10.1016/j.surg.2021.08.029] [Reference Citation Analysis]
244 Lerut T, Coosemans W, Decker G, De Leyn P, Moons J, Nafteux P, Van Raemdonck D. Extended surgery for cancer of the esophagus and gastroesophageal junction. Journal of Surgical Research 2004;117:58-63. [DOI: 10.1016/j.jss.2003.12.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
245 Shen Y, Zhang Y, Tan L, Feng M, Wang H, Khan MA, Liang M, Wang Q. Extensive mediastinal lymphadenectomy during minimally invasive esophagectomy: optimal results from a single center. J Gastrointest Surg 2012;16:715-21. [PMID: 22258878 DOI: 10.1007/s11605-012-1824-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
246 He Y, Mingyan E, Wang C, Liu G, Shi M, Liu S. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway. Int J Biol Macromol 2019;125:116-23. [PMID: 30508543 DOI: 10.1016/j.ijbiomac.2018.11.273] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
247 Xu Y, Chen Q, Yu X, Zhou X, Zheng X, Mao W. Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases. Oncol Lett. 2013;5:185-190. [PMID: 23255917 DOI: 10.3892/ol.2012.1007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
248 Miyata H, Yano M, Doki Y, Yasuda T, Yoshioka S, Sugita Y, Takiguchi S, Fujiwara Y, Monden M. A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes. J Surg Oncol 2006;93:477-84. [DOI: 10.1002/jso.20453] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
249 Fink U, Stein H, Bochtler H, Roder J, Wilke H, Siewert J. Esophageal Cancer: Neoadjuvant therapy for squamous cell esophageal carcinoma. Annals of Oncology 1994;5:S17-26. [DOI: 10.1093/annonc/5.suppl_3.s17] [Cited by in Crossref: 42] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
250 Ye B, Zhong CX, Yang Y, Fang WT, Mao T, Ji CY, Li ZG. Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery. World J Gastroenterol 2016; 22(19): 4750-4756 [PMID: 27217706 DOI: 10.3748/wjg.v22.i19.4750] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
251 Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 2010;127:2804-14. [PMID: 21351259 DOI: 10.1002/ijc.25284] [Cited by in Crossref: 328] [Cited by in F6Publishing: 332] [Article Influence: 29.8] [Reference Citation Analysis]
252 Yamashita K, Makino T, Yamasaki M, Tanaka K, Hara T, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer. Dis Esophagus 2017;30:1-8. [PMID: 28881906 DOI: 10.1093/dote/dox096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
253 Tachibana M, Tabara H, Kotoh T, Kinugasa S, Dhar DK, Hishikawa Y, Masunaga R, Kubota H, Nagasue N. Prognostic Significance of Perioperative Blood Transfusions in Resectable Thoracic Esophageal Cancer. American Journal of Gastroenterology 1999;94:757-65. [DOI: 10.1111/j.1572-0241.1999.00948.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
254 Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Mori M, Doki Y. Multimodal treatment for resectable esophageal cancer. Gen Thorac Cardiovasc Surg 2011;59:461-6. [PMID: 21751104 DOI: 10.1007/s11748-011-0780-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
255 Ikeguchi M, Katano K, Oka A, Tsujitani S, Maeta M, Kaibara N. Number of argyrophilic nucleolar organizer regions is a good indicator of lymph node metastasis in patients with esophageal carcinoma. Langenbecks Arch Chir 1995;380:197-202. [PMID: 7674793 DOI: 10.1007/BF00207907] [Reference Citation Analysis]
256 Suzuki H, Saito Y, Oda I, Kikuchi T, Kiriyama S, Fukunaga S. Comparison of narrowband imaging with autofluorescence imaging for endoscopic visualization of superficial squamous cell carcinoma lesions of the esophagus. Diagn Ther Endosc 2012;2012:507597. [PMID: 23197931 DOI: 10.1155/2012/507597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
257 Loevner LA. Anatomic and functional lesions resulting in partial or complete upper airway obstruction. Seminars in Roentgenology 2001;36:12-20. [DOI: 10.1053/sroe.2001.21447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
258 Xie JJ, Xie YM, Chen B, Pan F, Guo JC, Zhao Q, Shen JH, Wu ZY, Wu JY, Xu LY, Li EM. ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma. Oncotarget 2014;5:8569-82. [PMID: 25149542 DOI: 10.18632/oncotarget.2322] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
259 Ohkura Y, Ueno M, Iizuka T, Udagawa H. Effectiveness of lymphadenectomy along the thoracic duct for radical esophagectomy. Esophagus 2021. [PMID: 34333712 DOI: 10.1007/s10388-021-00868-4] [Reference Citation Analysis]
260 Wobst A, Audisio RA, Colleoni M, Geraghty JG. Oesophageal cancer treatment: studies, strategies and facts. Ann Oncol. 1998;9:951-962. [PMID: 9818067 DOI: 10.1023/A:1008273110272] [Cited by in Crossref: 48] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
261 Ishihara R, Yamamoto S, Iishi H, Takeuchi Y, Sugimoto N, Higashino K, Uedo N, Tatsuta M, Yano M, Imai A. Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2010;76:123-129. [PMID: 19386426 DOI: 10.1016/j.ijrobp.2009.01.038] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
262 Mine S, Udagawa H, Tsutsumi K, Kinoshita Y, Ueno M, Ehara K, Haruta S. Colon interposition after esophagectomy with extended lymphadenectomy for esophageal cancer. Ann Thorac Surg. 2009;88:1647-1653. [PMID: 19853126 DOI: 10.1016/j.athoracsur.2009.05.081] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
263 Kang Y, Hwang Y, Lee HJ, Park IK, Kim YT, Kang CH. Patterns and Prognostic Significance of Cervical Lymph Node Metastasis and the Efficacy of Cervical Node Dissection in Esophageal Cancer. Korean J Thorac Cardiovasc Surg 2017;50:329-38. [PMID: 29124024 DOI: 10.5090/kjtcs.2017.50.5.329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
264 Nishimura Y, Osugi H, Inoue K, Takada N, Takamura M, Kinosita H. Bronchoscopic ultrasonography in the diagnosis of tracheobronchial invasion of esophageal cancer. J Ultrasound Med 2002;21:49-58. [PMID: 11794402 DOI: 10.7863/jum.2002.21.1.49] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
265 Lerut TE, de Leyn P, Coosemans W, Van Raemdonck D, Cuypers P, Van Cleynenbreughel B. Advanced esophageal carcinoma. World J Surg 1994;18:379-87. [DOI: 10.1007/bf00316818] [Cited by in Crossref: 42] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
266 Delgado Gomis F, Gómez Abril SA, Martínez Abad M, Guallar Rovira JM. Assisted laparoscopic transhiatal esophagectomy for the treatment of esophageal cancer. Clin Transl Oncol 2006;8:185-92. [PMID: 16648118 DOI: 10.1007/s12094-006-0009-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
267 Hiranyatheb P, Osugi H. Radical lymphadenectomy in esophageal cancer: from the past to the present. Dis Esophagus. 2013;Jun 24; Epub ahead of print. [PMID: 23796327 DOI: 10.1111/dote.12091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
268 Sohda M, Kuwano H. Current Status and Future Prospects for Esophageal Cancer Treatment. Ann Thorac Cardiovasc Surg. 2017;23:1-11. [PMID: 28003586 DOI: 10.5761/atcs.ra.16-00162] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 13.8] [Reference Citation Analysis]
269 Kaburagi T, Takeuchi H, Kawakubo H, Omori T, Ozawa S, Kitagawa Y. Clinical utility of a novel hybrid position combining the left lateral decubitus and prone positions during thoracoscopic esophagectomy. World J Surg 2014;38:410-8. [PMID: 24101023 DOI: 10.1007/s00268-013-2258-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
270 Wang Y, Zhu L, Xia W, Wang F. Anatomy of lymphatic drainage of the esophagus and lymph node metastasis of thoracic esophageal cancer. Cancer Manag Res. 2018;10:6295-6303. [PMID: 30568491 DOI: 10.2147/cmar.s182436] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
271 Fujisawa K, Ohkura Y, Ueno M, Yago A, Shimoyama H, Udagawa H. Nutritional Outcomes of Thoracic Duct Resection for Radical Esophagectomy by Assessing Body Composition Changes in One Year: A Single-Center Retrospective Study. Ann Surg Oncol 2021. [PMID: 34085142 DOI: 10.1245/s10434-021-10222-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 Tamaki Y, Sasaki R, Ejima Y, Ogura M, Negoro Y, Nakajima T, Murakami M, Kaji Y, Sugimura K. Efficacy of intraoperative radiotherapy targeted to the abdominal lymph node area in patients with esophageal carcinoma. J Radiat Res 2012;53:882-91. [PMID: 22872778 DOI: 10.1093/jrr/rrs045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
273 Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I, Triboulet JP. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97:1616-1623. [PMID: 12655517 DOI: 10.1002/cncr.11228] [Cited by in Crossref: 258] [Cited by in F6Publishing: 243] [Article Influence: 13.6] [Reference Citation Analysis]
274 Shimada H, Nabeya Y, Matsubara H, Okazumi S, Shiratori T, Shimizu T, Aoki T, Shuto K, Akutsu Y, Ochiai T. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg. 2006;191:250-254. [PMID: 16442955 DOI: 10.1016/j.amjsurg.2005.07.035] [Cited by in Crossref: 96] [Cited by in F6Publishing: 94] [Article Influence: 6.0] [Reference Citation Analysis]
275 Leng XF, Zhu Y, Wang GP, Jin J, Xian L, Zhang YH. Accuracy of ultrasound for the diagnosis of cervical lymph node metastasis in esophageal cancer: a systematic review and meta-analysis. J Thorac Dis 2016;8:2146-57. [PMID: 27621871 DOI: 10.21037/jtd.2016.07.71] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
276 Martin DJ, Church NG, Kennedy CW, Falk GL. Does systematic 2-field lymphadenectomy for esophageal malignancy offer a survival advantage? Results from 178 consecutive patients. Dis Esophagus. 2008;21:612-618. [PMID: 18459992 DOI: 10.1111/j.1442-2050.2008.00826.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
277 Tachibana M, Kinugasa S, Dhar DK, Kotoh T, Shibakita M, Ohno S, Masunaga R, Kubota H, Kohno H, Nagasue N. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol 1999;72:88-93. [DOI: 10.1002/(sici)1096-9098(199910)72:2<88::aid-jso9>3.0.co;2-v] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
278 Fujita H, Kakegawa T, Yamana H, Hölscher AH, Bollschweiler E, Siewert JR. The Results of En Bloc Esophagectomy Compared with Three-Field and Two-Field Dissection. In: Nabeya K, Hanaoka T, Nogami H, editors. Recent Advances in Diseases of the Esophagus. Tokyo: Springer Japan; 1993. pp. 703-8. [DOI: 10.1007/978-4-431-68246-2_115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
279 Grimm JC, Valero V, Molena D. Surgical indications and optimization of patients for resectable esophageal malignancies. J Thorac Dis. 2014;6:249-257. [PMID: 24624289 DOI: 10.3978/j.issn.2072-1439.2013.11.18] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
280 Hennessy TPJ. Lymph node dissection. World J Surg 1994;18:367-72. [DOI: 10.1007/bf00316816] [Cited by in Crossref: 21] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
281 Moris D, Mantonakis E, Makris M, Michalinos A, Vernadakis S. Hoarseness after thyroidectomy: blame the endocrine surgeon alone? Hormones (Athens) 2014;13:5-15. [PMID: 24722123 DOI: 10.1007/BF03401316] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
282 Ren Y, Su C, Zhou Y, Zhao X, Yang CL, Liu YY. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma. World J Gastroenterol 2014; 20(47): 17970-17975 [PMID: 25548496 DOI: 10.3748/wjg.v20.i47.17970] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
283 Schneider PM, Vallböhmer D, Brabender J, Hölscher AH. [Preoperative evaluation of prognostic factors in esophageal squamous cell cancer]. Chirurg 2005;76:1011-7. [PMID: 16247636 DOI: 10.1007/s00104-005-1109-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
284 Altorki N. En-bloc esophagectomy--the three-field dissection. Surg Clin North Am 2005;85:611-9, xi. [PMID: 15927655 DOI: 10.1016/j.suc.2005.01.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
285 Nusrath S, Saxena AR, Raju KVVN, Patnaik S, Subramanyeshwar Rao T, Bollineni N. The Value of Lymphadenectomy Post-Neoadjuvant Therapy in Carcinoma Esophagus: a Review. Indian J Surg Oncol 2020;11:538-48. [PMID: 33013140 DOI: 10.1007/s13193-020-01156-w] [Reference Citation Analysis]
286 Matsubara H. Neoadjuvant chemoradiation therapy for the treatment of esophageal carcinoma. Int J Clin Oncol 2008;13:474-8. [PMID: 19093172 DOI: 10.1007/s10147-008-0853-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
287 Sgourakis G, Gockel I, Lyros O, Lanitis S, Dedemadi G, Polotzek U, Karaliotas C, Lang H. The Use of Neural Networks in Identifying Risk Factors for Lymph Node Metastasis and Recommending Management of T1b Esophageal Cancer. The American Surgeon 2012;78:195-206. [DOI: 10.1177/000313481207800238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
288 Kato H, Nakajima M. Treatments for esophageal cancer: a review. Gen Thorac Cardiovasc Surg 2013;61:330-5. [PMID: 23568356 DOI: 10.1007/s11748-013-0246-0] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 8.7] [Reference Citation Analysis]
289 Sato F, Shimada Y, Li Z, Kano M, Watanabe G, Maeda M, Kawabe A, Kaganoi J, Itami A, Nagatani S, Imamura M. Paratracheal lymph node metastasis is associated with cervical lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma. Ann Surg Oncol 2002;9:65-70. [DOI: 10.1245/aso.2002.9.1.65] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
290 Gervasoni JE, Taneja C, Chung MA, Cady B. Biologic and clinical significance of lymphadenectomy. Surg Clin North Am. 2000;80:1631-1673. [PMID: 11140865 DOI: 10.1016/s0039-6109(05)70253-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
291 Nozoe T, Kakeji Y, Baba H, Maehara Y. Two-field lymph-node dissection may be enough to treat patients with submucosal squamous cell carcinoma of the thoracic esophagus. Dis Esophagus. 2005;18:226-229. [PMID: 16128778 DOI: 10.1111/j.1442-2050.2005.00482.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
292 Sato N, Koeda K, Ikeda K, Kimura Y, Aoki K, Iwaya T, Akiyama Y, Ishida K, Saito K, Endo S. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236:184-190. [PMID: 12170023 DOI: 10.1097/00000658-200208000-00006] [Cited by in Crossref: 130] [Cited by in F6Publishing: 117] [Article Influence: 6.5] [Reference Citation Analysis]
293 Koyanagi K, Ozawa S, Tachimori Y. Minimally invasive esophagectomy performed with the patient in a prone position: a systematic review. Surg Today 2016;46:275-84. [DOI: 10.1007/s00595-015-1164-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
294 Chang X, Deng W, Wang X, Zhou Z, Yang J, Guo W, Liu M, Qi X, Li L, Zhang K, Zhang M, Shi Y, Liu K, Zhao Y, Wang H, Yu Z, Zhang J, Wang L, Qiao X, Han C, Zhu S, Zhang R, Chen J, Hu C, Zhang F, Hou X, Pang Q, Zhang W, Li G, Lin H, Sun X, Ge X, Li C, Ge H, Li D, Wang Y, Lu N, Gao X, Qin S, Tian Y, Xiao Z. Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China. Radiat Oncol 2021;16:102. [PMID: 34107984 DOI: 10.1186/s13014-020-01691-4] [Reference Citation Analysis]
295 Ide H, Nakamura T, Hayashi K, Eguchi R, Tanigawa K, Ota M. Neoadjuvant chemotherapy with cisplatinum/5-fluorouracil/low-dose leucovorin for advanced squamous cell carcinoma of the esophagus. Semin Surg Oncol 1997;13:263-9. [DOI: 10.1002/(sici)1098-2388(199707/08)13:4<263::aid-ssu8>3.0.co;2-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
296 Watanabe H, Kato H, Tachimori Y. Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan. Recent Results Cancer Res 2000;155:123-33. [PMID: 10693246 DOI: 10.1007/978-3-642-59600-1_13] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
297 Hennessy TP. Cancer of the oesophagus. Postgrad Med J 1996;72:458-63. [PMID: 8796207 DOI: 10.1136/pgmj.72.850.458] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
298 Fujita H. History of the Japanese Classification of Esophageal Cancer. Esophagus 2011;8:233-45. [DOI: 10.1007/s10388-011-0292-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
299 Li Z, Wu X, Gu L, Shen Q, Luo W, Deng C, Zhou Q, Chen X, Li Y, Lim Z, Wang X, Wang J, Yang X. Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis. Cell Death Dis 2017;8:e2888. [PMID: 28640252 DOI: 10.1038/cddis.2017.245] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 9.6] [Reference Citation Analysis]
300 Lee Y, Fujita H, Yamana H, Kakegawa T. Factors affecting leakage following esophageal anastomosis. Surg Today 1994;24:24-9. [DOI: 10.1007/bf01676880] [Cited by in Crossref: 62] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
301 Chen JX, Lu TY, Fang HY, Lin YS, Lee JM. The Impact of Pretreatment PET/CT Nodal Status on Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiation. World J Surg 2020;44:2323-31. [PMID: 32296872 DOI: 10.1007/s00268-020-05481-7] [Reference Citation Analysis]
302 Kranzfelder M, Büchler P, Friess H. Surgery within multimodal therapy concepts for esophageal squamous cell carcinoma (ESCC): the MRI approach and review of the literature. Adv Med Sci. 2009;54:158-169. [PMID: 20022858 DOI: 10.2478/v10039-009-0044-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
303 Shiozaki H, Yano M, Tsujinaka T, Inoue M, Tamura S, Doki Y, Yasuda T, Fujiwara Y, Monden M. Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esophagus. 2001;14:191-196. [PMID: 11869318 DOI: 10.1046/j.1442-2050.2001.00206.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 3.3] [Reference Citation Analysis]
304 Krasna MJ, Mao Y. Making Sense of Multimodality Therapy for Esophageal Cancer. Surgical Oncology Clinics of North America 1999;8:259-78. [DOI: 10.1016/s1055-3207(18)30212-6] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
305 Akutsu Y, Kato K, Igaki H, Ito Y, Nozaki I, Daiko H, Yano M, Udagawa H, Nakagawa S, Takagi M, Mizusawa J, Kitagawa Y. The Prevalence of Overall and Initial Lymph Node Metastases in Clinical T1N0 Thoracic Esophageal Cancer: From the Results of JCOG0502, a Prospective Multicenter Study. Ann Surg 2016;264:1009-15. [PMID: 27420375 DOI: 10.1097/SLA.0000000000001557] [Cited by in Crossref: 42] [Cited by in F6Publishing: 17] [Article Influence: 8.4] [Reference Citation Analysis]
306 Li H, Zhang Y, Cai H, Xiang J. Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy. Eur Surg Res. 2007;39:1-6. [PMID: 17106199 DOI: 10.1159/000096925] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
307 Kranzfelder M, Büchler P, Lange K, Friess H. Treatment options for squamous cell cancer of the esophagus: a systematic review of the literature. J Am Coll Surg 2010;210:351-9. [PMID: 20193900 DOI: 10.1016/j.jamcollsurg.2009.12.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
308 Murakami M, Kuroda Y, Nakajima T, Okamoto Y, Mizowaki T, Kusumi F, Hajiro K, Nishimura S, Matsusue S, Takeda H. Intraoperative radiotherapy for the abdominal lymphatic system in patients with esophageal carcinoma. Diseases of the Esophagus 1999;12:270-5. [DOI: 10.1046/j.1442-2050.1999.00050.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
309 Gee DW, Rattner DW. Management of gastroesophageal tumors. Oncologist. 2007;12:175-185. [PMID: 17296813 DOI: 10.1634/theoncologist.12-2-175] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
310 Bessell JR, Devitt PG, Gill PG, Goyal S, Jamieson GG. PROLONGED SURVIVAL FOLLOWS RESECTION OF OESOPHAGEAL SCC DOWNSTAGED BY PRIOR CHEMORADIOTHERAPY. ANZ J Surg 1996;66:214-7. [DOI: 10.1111/j.1445-2197.1996.tb01167.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
311 Shimada H, Shiratori T, Okazumi S, Matsubara H, Shuto K, Akutsu Y, Narushima K, Nabeya Y, Hayashi H, Ochiai T. Surgical Outcome of Elderly Patients 75 Years of Age and Older with Thoracic Esophageal Carcinoma. World J Surg 2007;31:773-9. [DOI: 10.1007/s00268-007-0606-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
312 Okawa T, Tanaka M, Kita M, Kaneyasu Y, Karasawa K, Ide H, Murata Y, Yamada A. Radiotherapy for superficial esophageal cancer. International Journal of Radiation Oncology*Biology*Physics 1994;30:959-64. [DOI: 10.1016/0360-3016(94)90372-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
313 Xia W, Qiu M, Chen R, Wang S, Leng X, Wang J, Xu Y, Hu J, Dong G, Xu PL, Yin R. Circular RNA has_circ_0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation. Sci Rep 2016;6:35576. [PMID: 27752108 DOI: 10.1038/srep35576] [Cited by in Crossref: 161] [Cited by in F6Publishing: 182] [Article Influence: 26.8] [Reference Citation Analysis]
314 Maeda N, Shirakawa Y, Tanabe S, Sakurama K, Noma K, Fujiwara T. Skeletal muscle loss in the postoperative acute phase after esophageal cancer surgery as a new prognostic factor. World J Surg Oncol 2020;18:143. [PMID: 32591002 DOI: 10.1186/s12957-020-01908-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
315 Yano M, Miyata H, Sugimura K, Motoori M, Omori T, Fujiwara Y, Miyoshi N, Yasui M, Ohue M, Akita H, Tomokuni A, Takahashi H, Kobayashi S, Sakon M. 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the prediction of survival in patients with advanced esophageal cancer who have undergone neoadjuvant chemotherapy. Mol Clin Oncol 2018;8:434-40. [PMID: 29456850 DOI: 10.3892/mco.2018.1546] [Reference Citation Analysis]
316 Murata S, Kato H, Tamura H, Tachimori Y, Watanabe H, Yamaguchi H, Nakanishi Y. Second primary carcinoma in the residual cervical esophagus after thoracic esophagectomy: Report of five cases. J Surg Oncol 1997;66:130-3. [DOI: 10.1002/(sici)1096-9098(199710)66:2<130::aid-jso11>3.0.co;2-7] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
317 Kato H, Igaki H, Tachimori Y, Watanabe H, Tsubosa Y, Nakanishi Y. Assessment of cervical lymph node metastasis in the staging of thoracic esophageal carcinoma. J Surg Oncol 2000;74:282-5. [PMID: 10962461 DOI: 10.1002/1096-9098(200008)74:4<282::aid-jso8>3.0.co;2-r] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
318 Nishihira T, Nakano T, Mori S. Adjuvant therapies for cancer of the thoracic esophagus. World J Surg 1994;18:388-98. [DOI: 10.1007/bf00316819] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
319 Fujiwara Y, Fukuda S, Tsujie M, Kitani K, Yukawa M, Inoue M, Watanabe Y, Higashida M, Kubota H, Okada T, Tsuruta A, Ueno T. Clinical significance of preoperative chemoradiotherapy for advanced esophageal cancer, evaluated by propensity score matching and weighting of inverse probability of treatment. Mol Clin Oncol 2019;10:575-82. [PMID: 31086666 DOI: 10.3892/mco.2019.1843] [Reference Citation Analysis]
320 Suzuki T, Kuwabara Y, Iwata H, Mitani M, Shinoda N, Sato A, Mitsui A, Sugiura M, Kato J, Fujii Y. Role of matrix metalloproteinase-9 in in vitro invasion of esophageal carcinoma cells. J Surg Oncol. 2002;81:80-86. [PMID: 12355408 DOI: 10.1002/jso.10134] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
321 Kobayashi S, Koide Y, Endo M, Isono K, Ochiai T. The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability. Am J Surg. 1999;177:497-502. [PMID: 10414702 DOI: 10.1016/s0002-9610(99)00085-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
322 Thakur B, Li H, Devkota M. Results of management of esophageal and GE junction malignancies in Nepalese context. J Thorac Dis 2013;5:123-8. [PMID: 23585936 DOI: 10.3978/j.issn.2072-1439.2013.03.07] [Reference Citation Analysis]
323 Shang QX, Yang YS, Hu WP, Yuan Y, Ji AF, Chen LQ. Prognostic significance and role of thoracic lymph node metastasis based on Chinese expert consensus in esophageal cancer. Ann Transl Med 2019;7:381. [PMID: 31555695 DOI: 10.21037/atm.2019.07.63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
324 Chandarana M, Jiwnani S, Karimundackal G, Pramesh CS. Lymphadenectomy in esophageal cancer: the real issues. Ann Thorac Surg 2014;98:389-90. [PMID: 24996739 DOI: 10.1016/j.athoracsur.2014.01.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
325 Etoh T, Inoue H, Yoshikawa Y, Barnard GF, Kitano S, Mori M. Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. Gut. 2000;47:50-56. [PMID: 10861264 DOI: 10.1136/gut.47.1.50] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 2.7] [Reference Citation Analysis]
326 Okazumi S, Ochiai T, Shimada H, Matsubara H, Nabeya Y, Miyazawa Y, Shiratori T, Aoki T, Sugaya M. Development of less invasive surgical procedures for thoracic esophageal cancer. Dis Esophagus 2004;17:159-63. [PMID: 15230731 DOI: 10.1111/j.1442-2050.2004.00379.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]